A Patently Generic Win
The US Supreme Court’s decision in Caraco vs. Novo Nordisk clarifies the rights of generic drug manufacturers to challenge overly broad patent claims. This case marks a significant…
2 articles
The US Supreme Court’s decision in Caraco vs. Novo Nordisk clarifies the rights of generic drug manufacturers to challenge overly broad patent claims. This case marks a significant…
This post evaluates the impact of the proposed Dog ate my Homework Act on patent term extension deadlines at the USPTO. It focuses on deadline miscalculations in pharmaceutical…